Literature DB >> 34742624

Functions of macrophage colony-stimulating factor (CSF1) in development, homeostasis, and tissue repair.

Anuj Sehgal1, Katharine M Irvine1, David A Hume2.   

Abstract

Macrophage colony-stimulating factor (CSF1) is the primary growth factor required for the control of monocyte and macrophage differentiation, survival, proliferation and renewal. Although the cDNAs encoding multiple isoforms of human CSF1 were cloned in the 1980s, and recombinant proteins were available for testing in humans, CSF1 has not yet found substantial clinical application. Here we present an overview of CSF1 biology, including evolution, regulation and functions of cell surface and secreted isoforms. CSF1 is widely-expressed, primarily by cells of mesenchymal lineages, in all mouse tissues. Cell-specific deletion of a floxed Csf1 allele in mice indicates that local CSF1 production contributes to the maintenance of tissue-specific macrophage populations but is not saturating. CSF1 in the circulation is controlled primarily by receptor-mediated clearance by macrophages in liver and spleen. Administration of recombinant CSF1 to humans or animals leads to monocytosis and expansion of tissue macrophage populations and growth of the liver and spleen. In a wide variety of tissue injury models, CSF1 administration promotes monocyte infiltration, clearance of damaged cells and repair. We suggest that CSF1 has therapeutic potential in regenerative medicine.
Copyright © 2021. Published by Elsevier Ltd.

Entities:  

Keywords:  CSF1; Development; MCSF; Macrophages

Mesh:

Substances:

Year:  2021        PMID: 34742624     DOI: 10.1016/j.smim.2021.101509

Source DB:  PubMed          Journal:  Semin Immunol        ISSN: 1044-5323            Impact factor:   11.130


  3 in total

Review 1.  CSF1R as a Therapeutic Target in Bone Diseases: Obvious but Not so Simple.

Authors:  David A Hume; Lena Batoon; Anuj Sehgal; Sahar Keshvari; Katharine M Irvine
Journal:  Curr Osteoporos Rep       Date:  2022-10-05       Impact factor: 5.163

2.  Significant Sex Differences in the Efficacy of the CSF1R Inhibitor-PLX5622 on Rat Brain Microglia Elimination.

Authors:  Aviv Sharon; Hadas Erez; Micha E Spira
Journal:  Pharmaceuticals (Basel)       Date:  2022-05-02

Review 3.  Microglial polarization in TBI: Signaling pathways and influencing pharmaceuticals.

Authors:  Yun-Fei Li; Xu Ren; Liang Zhang; Yu-Hai Wang; Tao Chen
Journal:  Front Aging Neurosci       Date:  2022-08-01       Impact factor: 5.702

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.